IXJ ETF

The healthcare sector is overvalued by 18% relative to 11-year averages, with pharmaceuticals/biotechnology and healthcare equipment most overpriced. IXJ offers global healthcare exposure with lower concentration in top holdings compared to XLV, but still has 72% of assets in U.S. companies. 10 stocks cheaper than their peers in November.

Monthly article series showing healthcare industry metrics. The healthcare sector is overvalued by about 18% relative to 11-year averages. The most overvalued subsector is pharmaceuticals and biotechnology.

iShares Global Healthcare ETF has underperformed the S&P 500 index in the past few years. IXJ has lower volatility and downside risk compared to the broader market. The healthcare sector is expected to have strong earnings growth in 2024 and 2025, making IXJ an attractive investment.

The healthcare sector is overvalued by about 13% relative to 11-year averages, but overvaluation varies a lot across subsectors. Healthcare equipment has the worst value and quality scores. iShares Global Healthcare ETF is a global alternative to XLV.

The healthcare sector valuation is close to 11-year averages. Pharmaceuticals/biotechnology and life science tools are close to the historical baseline, while healthcare equipment is the less attractive subsector. iShares Global Healthcare ETF is a global alternative to Healthcare Select Sector SPDR Fund ETF.

The sector as a whole is overvalued by about 15% relative to 11-year averages. Healthcare providers and pharmaceuticals/biotechnology look fairly valued, whereas healthcare equipment is the less attractive subsector. IXJ: a global alternative to XLV.

As the populations of most wealthy countries continue to age, the healthcare sector is going to benefit irrespective of economic conditions. Investors are continuing to opt for stocks from safer sectors like health care until a better and certain macroeconomic environment starts prevailing. Despite exposing itself to pharmaceutical and biotechnology sectors, iShares Global Healthcare ETF remained steady and generated decent price growth over the past five years.

Exchange-traded funds can provide investors with an easy way to diversify and keep risk down. Healthcare and consumer staples are two areas that investors can target with ETFs.